Cargando…

Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience

Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with resectable CRLM in our center. We retrospectively a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassabein, Rami, Mansour, Laura, Richard, Corentin, Vandenbroucke-Menu, Franck, Aubin, Francine, Ayoub, Jean-Pierre, Dagenais, Michel, Lapointe, Real, Letourneau, Richard, Plasse, Marylène, Roy, André, Turcotte, Simon, Tehfe, Mustapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161835/
https://www.ncbi.nlm.nih.gov/pubmed/34069871
http://dx.doi.org/10.3390/curroncol28030176
_version_ 1783700587301306368
author Nassabein, Rami
Mansour, Laura
Richard, Corentin
Vandenbroucke-Menu, Franck
Aubin, Francine
Ayoub, Jean-Pierre
Dagenais, Michel
Lapointe, Real
Letourneau, Richard
Plasse, Marylène
Roy, André
Turcotte, Simon
Tehfe, Mustapha
author_facet Nassabein, Rami
Mansour, Laura
Richard, Corentin
Vandenbroucke-Menu, Franck
Aubin, Francine
Ayoub, Jean-Pierre
Dagenais, Michel
Lapointe, Real
Letourneau, Richard
Plasse, Marylène
Roy, André
Turcotte, Simon
Tehfe, Mustapha
author_sort Nassabein, Rami
collection PubMed
description Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with resectable CRLM in our center. We retrospectively analyzed characteristics and outcomes of older patients with CRLM operated at “Centre Hospitalier de l’Université de Montréal” (CHUM) between 2010 and 2019. We identified 210 patients aged ≥70 years with a median age of 76 (range: 70–85). CRLM were synchronous in 56% of patients. Median disease-free survival (DFS) was 41.3 months. Median overall survival (OS) was 62.2 months and estimated 5-year survival rate was 51.5% similar to those of younger counterparts. Patients with metachronous CRLM had a trend to a higher OS compared to those with synchronous disease (67.2 vs. 58.7 months; p = 0.42). Factors associated with lower survival in the multivariate analysis were right-sided tumors and increased Charlson Comorbidity index (CCI). Survival outcomes of patients aged ≥70 years were comparable to those of younger patients and those reported in the literature. Age should not be a limiting factor in the curative management of older patients with resectable CRLM.
format Online
Article
Text
id pubmed-8161835
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81618352021-05-29 Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience Nassabein, Rami Mansour, Laura Richard, Corentin Vandenbroucke-Menu, Franck Aubin, Francine Ayoub, Jean-Pierre Dagenais, Michel Lapointe, Real Letourneau, Richard Plasse, Marylène Roy, André Turcotte, Simon Tehfe, Mustapha Curr Oncol Article Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with resectable CRLM in our center. We retrospectively analyzed characteristics and outcomes of older patients with CRLM operated at “Centre Hospitalier de l’Université de Montréal” (CHUM) between 2010 and 2019. We identified 210 patients aged ≥70 years with a median age of 76 (range: 70–85). CRLM were synchronous in 56% of patients. Median disease-free survival (DFS) was 41.3 months. Median overall survival (OS) was 62.2 months and estimated 5-year survival rate was 51.5% similar to those of younger counterparts. Patients with metachronous CRLM had a trend to a higher OS compared to those with synchronous disease (67.2 vs. 58.7 months; p = 0.42). Factors associated with lower survival in the multivariate analysis were right-sided tumors and increased Charlson Comorbidity index (CCI). Survival outcomes of patients aged ≥70 years were comparable to those of younger patients and those reported in the literature. Age should not be a limiting factor in the curative management of older patients with resectable CRLM. MDPI 2021-05-18 /pmc/articles/PMC8161835/ /pubmed/34069871 http://dx.doi.org/10.3390/curroncol28030176 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nassabein, Rami
Mansour, Laura
Richard, Corentin
Vandenbroucke-Menu, Franck
Aubin, Francine
Ayoub, Jean-Pierre
Dagenais, Michel
Lapointe, Real
Letourneau, Richard
Plasse, Marylène
Roy, André
Turcotte, Simon
Tehfe, Mustapha
Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title_full Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title_fullStr Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title_full_unstemmed Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title_short Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
title_sort outcomes of older patients with resectable colorectal liver metastases cancer (crlm): single center experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161835/
https://www.ncbi.nlm.nih.gov/pubmed/34069871
http://dx.doi.org/10.3390/curroncol28030176
work_keys_str_mv AT nassabeinrami outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT mansourlaura outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT richardcorentin outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT vandenbrouckemenufranck outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT aubinfrancine outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT ayoubjeanpierre outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT dagenaismichel outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT lapointereal outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT letourneaurichard outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT plassemarylene outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT royandre outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT turcottesimon outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience
AT tehfemustapha outcomesofolderpatientswithresectablecolorectallivermetastasescancercrlmsinglecenterexperience